Lymphoid Enhancer-Binding Factor 1 (LEF1) (Intermediate Domain) Peptide
-
- Target See all LEF1 products
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
- Protein Region
- Intermediate Domain
- Origin
- Human, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- LEF1 peptide corresponds to 14 amino acids near the intermediate domain of LEF1.
-
-
- Application Notes
- LEF1 Peptide is used for blocking the activity of LEF1 antibody . The LEF1 antibody ships at 0.5 mg/mL and the LEF1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- LEF1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- LEF1 (Lymphoid Enhancer-Binding Factor 1 (LEF1))
- Synonyms
- LEF1 Peptide, 3000002B05 Peptide, AI451430 Peptide, Lef-1 Peptide, LEF-1 Peptide, TCF10 Peptide, TCF1ALPHA Peptide, TCF7L3 Peptide, lymphoid enhancer binding factor 1 Peptide, lymphoid enhancer-binding factor 1 Peptide, lymphoid enhancer factor XLEF-1B Peptide, LEF1 Peptide, lef1 Peptide, Lef1 Peptide
- Gene ID
- 51176
- NCBI Accession
- NP_057353
- OMIM
- 7705917
- UniProt
- Q9UJU2
-